Fujimori, Y., Katsuno, K., Nakashima, I., Ishikawa-Takemura, Y., Fujikura, H. and Isaji, M. (2008) Remogliflozin Etabonate, in a Novel Category of Selective Low-Affinity Sodium Glucose Cotransporter (SGLT2) Inhibitors, Exhibits Antidiabetic Efficacy in Rodent Models. Journal of Pharmacology and Experimental Therapeutics, 327, 268-276.
https://doi.org/10.1124/jpet.108.140210

has been cited by the following article: